Corina Antal retweetledi

Proud to see MCC member Fleur Ferguson, PhD, named a 2026 Pershing Square Sohn Cancer Prize recipient, one of 13 nationwide.
Her work advances a new class of “activity-dependent” degrader therapies to target cancer-driving proteins while sparing healthy ones, unlocking new therapeutic possibilities.
Great example of innovation driving impact at Moores. Congrats!
Read more: bwnews.pr/4waYcHD

English
























